John Bovill References: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
No edit summary
 
(54 intermediate revisions by 2 users not shown)
Line 1: Line 1:
==Information==
 
*https://stemcells.nih.gov/info.htm
=Overview=
*https://cbhd.org/stem-cell-research/overview
* 1. "Stem Cell Information." National Institutes of Health. U.S. Department of Health and Human Services, 2016.  Available at <https://stemcells.nih.gov/info.htm >
*http://onlinelibrary.wiley.com/doi/10.1634/stemcells.2005-0188/full
* 2. Bevington, Linda. "An Overview of Stem Cell Research." The Center for Bioethics and Human Dignity. Trinity International University, Aug. 2009. Available at <https://cbhd.org/stem-cell-research/overview>
*https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206984/
* 3. Kitchener, Wilson D., Dr., and Joesph C. Wu, Dr. "Induced Pluripotent Stem Cells." JAMA Network 313.16 (201`5): 1613-614. Available at <http://jamanetwork.com/journals/jama/fullarticle/2279720>
==Images==
 
{{Template:Matthew R Allegretti John Bovill Stem Cell Project}}
=Immune rejection=
*4. "Blood-Forming Stem Cell Transplants." National Cancer Institute. National Institutes of Health, 12 Aug. 2013. Available at <https://www.cancer.gov/about-cancer/treatment/types/stem-cell-transplant/stem-cell-fact-sheet>
*5. Drukker, Micha, Helena Katchman, Gil Katz, Elias Shezen, Eran Hornstein, and Yair Reisner. "Human Embryonic Stem Cells and Their Differentiated Derivatives Are Less Susceptible to Immune Rejection Than Adult Cells." Stem Cells 24.2 (2006): 221-29. Available at <http://onlinelibrary.wiley.com/doi/10.1634/stemcells.2005-0188/full >
*6. "Blood and Bone Marrow Transplant." National Institutes of Health. U.S. Department of Health and Human Services, 9 Dec. 2016. Available at <https://www.nhlbi.nih.gov/health/health-topics/topics/bmsct>
 
=Stem Cells As a Research Tool=
* 7. Zuba-Surma, E. K., W. Wojakowski, Z. Madeja, and M. Z. Ratajczak. "Stem Cells as a Novel Tool for Drug Screening and Treatment of Degenerative Diseases." Current Pharmaceutical Design. U.S. National Library of Medicine, 2012. Available at <https://www.ncbi.nlm.nih.gov/pubmed/22512442>
* 8. Bruce Conklin Talks About Screening Drugs for Toxicity with Human Stem Cells. Prod. Jack Hubbard. Perf. Bruce Conklin. California Stem Cell Agency. California Institute for Regenerative Medicine, 17 Jan. 2009. Available at < https://www.cirm.ca.gov/our-progress/video/bruce-conklin-talks-about-screening-drugs-toxicity-human-stem-cells>
* 9. Cressey, Daniel. "Stem Cells Take Root in Drug Development." Nature News. Nature Publishing Group, 24 May 2012. Available at <http://www.nature.com/news/stem-cells-take-root-in-drug-development-1.10713 >
 
=Bone Marrow=
* 10. "Blood and Bone Marrow Transplant." National Institutes of Health. U.S. Department of Health and Human Services, 9 Dec. 2016. Available at <https://www.nhlbi.nih.gov/health/health-topics/topics/bmsct>
* 11. "Blood-Forming Stem Cell Transplants." National Cancer Institute. National Institutes of Health, 12 Aug. 2013. Available at <https://www.cancer.gov/about-cancer/treatment/types/stem-cell-transplant/stem-cell-fact-sheet>
* 12. Kim, H-J, W-S Min, Y-J Kim, D-W Kim, J-W Lee, and C-C Kim. "Haplotype Mismatched Transplantation Using High Doses of Peripheral Blood CD34 Cells Together with Stratified Conditioning Regimens for High-risk Adult Acute Myeloid Leukemia Patients: A Pilot Study in a Single Korean Institution." Bone Marrow Transplantation 35.10 (2005): 959-64. Available at <http://www.nature.com/bmt/journal/v35/n10/full/1704900a.html>
 
=Transplant rejection=
* 13. Martin, Laura J., Dr. "Transplant Rejection." MedlinePlus Medical Encyclopedia. N.p., 30 Apr. 2015. Available at <https://medlineplus.gov/ency/article/000815.htm>
 
=Organ Treatment=
* 14. Liu, Yunying, Ru Yang, Zuping He, and Wei-Qiang Gao. "Generation of Functional Organs from Stem Cells." Cell Regeneration 2.1 (2013): 1. Available at <https://cellregenerationjournal.biomedcentral.com/articles/10.1186/2045-9769-2-1 >
* 15. Bussolati, Benedetta. "Stem Cells for Organ Repair." Organogenesis 7.2 (2011): 95.  Available at <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142444/>
=Further Resources=
* 16. "What Is a Stem Cell Transplant (Bone Marrow Transplant)?" Cancer.Net. American Society of Clinical Oncology, 28 Jan. 2016. Available <http://www.cancer.net/navigating-cancer-care/how-cancer-treated/bone-marrowstem-cell-transplantation/what-stem-cell-transplant-bone-marrow-transplant >
* 17. Martin, Laura, Dr.U. "Transplant Rejection." MedlinePlus Medical Encyclopedia. U.S. National Library of Medicine, 2015. Available at <https://medlineplus.gov/ency/article/000815.htm>
* 18. Ikehara, Susumu. "Grand Challenges in Stem Cell Treatments." Frontiers in Cell and Developmental Biology 1 (2013): n. pag. Available at <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206984/pdf/fcell-01-00002.pdf>
* 19. Kim, Hyun-Jung and Yun Jin, Chang. "Stem Cells in Drug Screening for Neurodegenerative Disease." The Korean Journal of Physiology and Pharmacology (2012): 16(1): 1-9. Available at <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298819/ >.
 
==Table of Contents==
*[[John Bovill Stem Cell| Stem Cell Overview]]
*[[John Bovill Potential Uses|Potential Uses]]
**[[John Bovill Drug Testing| Drug Testing]]
**[[John Bovill Cell Based Therapy|Cell Based Therapy]]
*[[John Bovill Obstacles|Obstacles]]
**[[John Bovill Immune Rejection| Immune Rejection]]
**[[John Bovill Difficult Process| Difficulties in Creating Stem Cells]]
*[[John Bovill References|References]]

Latest revision as of 19:39, 1 May 2017

Overview

Immune rejection

Stem Cells As a Research Tool

Bone Marrow

Transplant rejection

Organ Treatment

Further Resources

Table of Contents

Retrieved from "https://openwetware.org/mediawiki/index.php?title=John_Bovill_References&oldid=986885"